Archive · 22 Jul 2026
Jubilant Ingrevia Q1 FY27 Profit Rises 22.46%
Jubilant Ingrevia Limited, a company that makes special chemicals and health products, recently shared its financial results for the first three months of the fiscal year 2027.
The company made a profit of ₹105.82 crore, which is a big increase from the previous quarter and the same time last year.
The company's total income was ₹1,310.49 crore.
The company also talked about its different business areas and some one-time expenses related to new labor laws.
Overall, the company is doing well, but it also has some challenges to face in the future.
Jubilant Ingrevia reported a net profit after tax of ₹105.82 crore for Q1 FY27, a 22.46% increase from the previous quarter.
Revenue from operations was ₹1,300.27 crore, up 10.32% from Q4 FY26 and 25.33% from Q1 FY26.
Total income for the quarter was ₹1,310.49 crore.
Profit before tax was ₹140.86 crore, compared to ₹111.71 crore in Q4 FY26 and ₹99.77 crore in Q1 FY26.
Basic earnings per share increased to ₹6.70 from ₹5.47 in the preceding quarter and ₹4.75 in the year-ago quarter.
- Who
- Jubilant Ingrevia Limited
- What
- Announced Q1 FY27 financial results
- When
- Quarter ended 30 June 2026
- Where
- Mumbai
- Why
- To report financial performance and growth
Positive Growth
Challenges Ahead
Financial Performance
Positive Growth
Strong revenue and profit growth indicate robust business performance.
Challenges Ahead
High expenses and exceptional items may pose future challenges.
- Net Profit After Tax (Q1 FY27)
- ₹105.82 crore
- Revenue from Operations (Q1 FY27)
- ₹1,300.27 crore
- Profit Before Tax (Q1 FY27)
- ₹140.86 crore
- Basic Earnings Per Share (Q1 FY27)
- ₹6.70
- Exceptional Items (Year Ended 31 March 2026)
- ₹13.04 crore